Immediate Recovery of Cognitive Functions and Resolution of Fatigue by Treatment with Weak Electromagnetic Fields in a Patient with Multiple Sclerosis

References

• Acuna-Castroviejo D., Rosenstein R. E., Romeo H. E., Cardinali D. P. Changes in gamma-aminobutyric acid high affinity binding to cerebral cortex membranes after pinealectomy or melatonin administration to rats. Neuroendocrinology 1986; 43: 24–31
   PubMed Web of Science ®Google Scholar
• Adams R. D., Victor M. Principles of neurology3rd Edition. McGraw-Hill Book Company, New York 1985; 699–717
   Google Scholar
• Aita J. F., Bennet D. R., Anderson R. E. Cranial CT appearance of acute multiple sclerosis. Neurology 1978; 28: 251–255
   PubMed Web of Science ®Google Scholar
• Aldegunde M., Miguez I., Veira J. Effects of pinealectomy on regional brain serotonin metabolism. International Journal of Neuroscience 1985; 26: 9–13
   PubMed Web of Science ®Google Scholar
• Anton-Tay F., Chou C., Anton S., Wurtman R. J. Brain serotonin concentration: elevation following intraperitoneal administration of melatonin. Science 1968; 162: 277–278
   PubMed Web of Science ®Google Scholar
• Bawin S. M., Adey W. R. Sensitivity of calcium binding in cerebral tissue to weak environmental electric fields oscillating at low frequency. Proceedings of the National Academyof Sciences, USA 1976; 73: 1999–2003
   PubMed Web of Science ®Google Scholar
• Beatty P. A., Gange J. J. Neuropsychological aspects of multiple sclerosis. Journal of Nervous and Mental Disease 1977; 164: 42–50
   PubMed Web of Science ®Google Scholar
• Beatty W. W., Goodkin D. E., Monson N., Beatty P. A., Hertsgaard D. Anterograde and retrograde amnesia in patients with chronic progressive multiple sclerosis. Archives of Neurology 1988; 45: 611–619
   PubMed Web of Science ®Google Scholar
• Beckwith B. E., Sandman C. A., Hothersall D., Kastin A. J. Influence of neonatal injections of alpha-MSH on learning, memory and attention in rats. Physiology & Behavior 1977; 18: 63–71
   PubMed Web of Science ®Google Scholar
• Benton A. L. Differential effects of frontal lobe disease. Neuropsychologia 1968; 6: 53–60
   Web of Science ®Google Scholar
• Bergin J. D. Rapidly progressing dementia in disseminated sclerosis. Journal of Neurology Neurosurgery and Psychiatry 1957; 20: 285–292
   PubMed Web of Science ®Google Scholar
• Blackman C. F. Stimulation of brain tissue in vitro by extremely low frequency, low intensity, sinusoidal electromagnetic fields. Electromagnetic fields and neurobehavioral function, M. E. O'Connor, R. H. Lovely. Alan R. Liss, New York 1988
   Google Scholar
• Bodis-Wollner I., Yahr M. D., Thornton J. Visual evoked potentials and the severity of Parkinson's disease. Rese arch progress in parkinson's disease, F. C. Rose, R. Capildeo. Pitman Medical, Kent 1981; 126–146
   Google Scholar
• Bodis-Wollner I., Yahr M. D., Mylin L., Thornton J. Dopaminergic deficiency and delayed visual evoked potentials in humans. Annals of Neurology 1982; 11: 478–83
   PubMed Web of Science ®Google Scholar
• Bradbury A. J., Kelly M. E., Smith J. A. Melatonin action in the mid-brain can regulate dopamine function both behaviourally and biochemically. The pineal gland: endocrine aspects, G. M. Brown, S. D. Wainwright. Pergamon Press, Oxford 1985; 327–332
   Google Scholar
• Brazier M. A. B. The electrical activity of the nenous system. The Williams and Wilkins Company, Baltimore 1968
   Google Scholar
• Bubenik G. A., Brown G. M., Grota J. L. Differential localization of N-acetyled indolalky lamines in CNS and the Harderian gland using immunohistology. Brain Research 1976; 118: 417–427
   PubMed Web of Science ®Google Scholar
• Caine E. D., Bamford H. A., Schiffer R. B. A controlled neuropsychological comparison of Huntington's disease and multiple sclerosis. Archives of Neurology 1986; 43: 249–254
   PubMed Web of Science ®Google Scholar
• Charcot J. M. Lectures on the diseases of the nervous system delivered at la salpetriere, G. Sigerson. The New Sydenham Society, London 1877; 194–195
   Google Scholar
• Claveria L. E., Curzon G., Harrison M. J. G., Kantamaneni B. D. Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology, Neurosurgery and Psvcliiatn 1974; 37: 715–718
   PubMed Web of Science ®Google Scholar
• Cummings D. E., Benson D. F. Subcortical dementia. Archives of Neurology 1986; 41: 874–879
   Google Scholar
• Davidson D., Pullar I. A., Mawdsley C., Kinloch N., Yates M. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1977; 40: 741–745
   PubMed Web of Science ®Google Scholar
• Diers W. C., Brown C. C. Psychometric patterns associated with multiple sclerosis. Archives of Neurology and Psychiatry 1950; 63: 760–765
   PubMedGoogle Scholar
• Erlich S. S., Apuzzo M. L. J. The pineal gland: anatomy, physiology, and clinical significance. Journal of Neurosurgery 1985; 63: 321–341
   PubMed Web of Science ®Google Scholar
• Fillcv C. M., Heaton R. K., Nelson L. M., Burks J. S., Franklin G. M. A comparison of dementia in Alzheimer's disease and multiple sclerosis. Archives of Neurology 1989; 46: 157–161
   PubMedGoogle Scholar
• Flax J. W., Gray J., Herbert J. Effect of fluoxetine on patients with multiple sclerosis. American Journal of Psychiatty 1991; 148: 1603
   PubMed Web of Science ®Google Scholar
• Franklin G. M., Nelson L. M., Filley C. M., Heaton R. K. Cognitive loss in multiple sclerosis. Case reports and review of the literature. Archives of Neurology 1989; 46: 162–167
   PubMed Web of Science ®Google Scholar
• Frederiks J. A. M. Disorders of the body schema. Handbook of clinical neurology: disorders of speech, perception, and symbolic behavior, P. J. Vinken, G. W. Bruyn. Elsevier Publishers, New York 1969; vol. 4: 207–240
   Google Scholar
• Georgi W. Multiple sclerose: pathologische-anatomische befunde multiple sclerose bei klinischnicht diagnostizierten krankheiten. Sclweizerischer Medizinische Wochenschrift 1961; 91: 605–607
   PubMed Web of Science ®Google Scholar
• Ghatak N. R., Hirano A., Lijtrmer H., Zimmerman H. M. Asymptomatic demyelinated plaque in the spinal cord. Archives of Neurology 1974; 30: 484–486
   PubMedGoogle Scholar
• Gilbert J. J., Sadler M. Unsuspected multiple sclerosis. Archives of Neurology 1983; 40: 533–536
   PubMedGoogle Scholar
• Goldstein G., Shelly C. H. Neuropsychological diagnosis of multiple sclerosis in a neuropsychiatric setting. Journal of Nervous and Mental Disease 1974; 158: 280–290
   PubMed Web of Science ®Google Scholar
• Gowers W. R. manual of diseases of the nenous system2nd Edition. Churchill, London 1893
   Google Scholar
• Grant I., McDonald W. I, Trimble M. R., Smith E., Reed R. Deficient learning and memory in early and middle phases of multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1984; 47: 250–255
   PubMed Web of Science ®Google Scholar
• Harrer G. Is the neurotransmitter system abnormal in multiple sclerosis?. Geriatric Medicine 1973; 3: 116–117
   Google Scholar
• Harrer G., Fischbach R. Ueber die wirkung bestimmter Aminosauren auf'das Ergebnis des Uenberwarmungstests bei Multiple Sklerose Kranken. Journal of Neural Transmission 1973; 34: 205–214
   PubMed Web of Science ®Google Scholar
• Heaton R. K., Nelson L. M., Thompson D. S. Neuropsychological findings in relapsing remitting and chronic progressive multiple sclerosis. Journal of Consulting Clinical Psychology 1985; 53: 103–110
   PubMed Web of Science ®Google Scholar
• Huber S. J., Paulson G. W., Shuttleworth E. C. Magnetic resonance imaging correlates of dementia in multiple sclerosis. Archives of Neurology 1987; 44: 732–736
   PubMed Web of Science ®Google Scholar
• Hyyppa M. T., Jolma T., Riekkinen P., Rmne U. K. Effects of L-tryptophan on central indoleamine metabolism and short-lasting neurologic disturbances in multiple sclerosis. Journal of Neural Transmission 1975; 37: 297–304
   PubMed Web of Science ®Google Scholar
• Ivnik R. J. Neuropsychological test performance as a function of the duration of MS-related symptomatology. Journal of Clinical Psychiatry 1978; 39: 304–312
   PubMed Web of Science ®Google Scholar
• Jaffe R. A., Laszewski B. L., Carr D. B., Phillips R. D. Chronic exposure to a 60-Hz electric field: effects on synaptic transmission and peripheral nerve function in the rat. Bioelectromagnetics 1980; 1: 131–147
   PubMedGoogle Scholar
• Jambor K. L. Cognitive functioning in multiple sclerosis. British Journal of Psychiatry 1969; 115: 765–775
   PubMed Web of Science ®Google Scholar
• Jennekens-Schinkel A., Sanders E. A. C. M. Decline of cognition in multiple sclerosis: dissociable deficits. Journal of Neurology Neurosurgery and Psychiatry 1986; 49: 1354–1360
   PubMed Web of Science ®Google Scholar
• Jewesbury E. C. O. Parietal lobe syndromes. Handbook of clinical neurology: localization in clinical neurology, P. J. Vinken, G. W. Bruyn. North Holland Publishing Company, Amsterdam 1969; vol. 2: 680–699
   Google Scholar
• Johansson B., Roos B. E. 5-hydroxyindoleacetic acid in cerebrospinal fluid of patients with neurological diseases. European Neurology 1974; 11: 37–45
   PubMed Web of Science ®Google Scholar
• Kahana E., Leibowitz U., Alter M. Cerebral multiple sclerosis. Neurology 1971; 21: 1179–1185
   PubMed Web of Science ®Google Scholar
• Kastin A. J., Miller L. H., Gonzalez-Barcena D., Hawley W. D, Dyster-Aas K., Schally A. V., de Parra M. L. V., Velasco M. Psychophysiologic correlates of MSH activity in man. Physiology & Behavior 1971; 7: 893–896
   PubMed Web of Science ®Google Scholar
• Kisser W., Harrer G. Amino acid determinations in serum of patients with multiple sclerosis. Wiener Klinische Wochenschrif 1974; 86: 80–82
   PubMed Web of Science ®Google Scholar
• Koopmans R. A., Li D. K. B., Oger J. J. F., Mayo J., Paty D. W. The lesion of multiple sclerosis: imaging of acute and chronic stages. Neurology 1989; 39: 959–963
   PubMed Web of Science ®Google Scholar
• Koya G., Suzuki M., Baba M., Iwabuchi T. An autopsy case of concurrence of multipl sclerosis and glioma. Hirosaki Medical Journal 1977; 29: 588–596
   Google Scholar
• Krupp L. B., Coyle P. K., Cross A. H., Dermit S., Friedman R. Amelioration of fatigue with pemoline in patients with multiple sclerosis. Annals of Neurology 1989; 26: 155–156
   Web of Science ®Google Scholar
• Lezak M. D. Neuropsychological assessmentThird Edition. Oxford University Press, New York 1995; 579–580
   Google Scholar
• Li D. K. B., Mayo J., Fache S., Robertson W., Lastrukoff L. F., Oger J., Paty D. W. Lack of correlation between clinical manifestations and lesions of MS as seen by NMR. Neurology 1984; 34: 136, suppl
   PubMed Web of Science ®Google Scholar
• Litvan I., Grafman J., Vendrell P., Martinez J. M. Slowed information processing in multiple sclerosis. Archives of Neurology 1988; 45: 281–285
   PubMed Web of Science ®Google Scholar
• Lynch S. G., Rose J. W., Smoker W., Petajan J. H. MRI in familial multiple sclerosis. Neurology 1990; 40: 900–903
   PubMed Web of Science ®Google Scholar
• Lyon-Caen O., Jouvet R., Hauser S. Cognitive function in recent onset demyelinating diseases. Archives of Neurology 1986; 43: 1138–1141
   PubMed Web of Science ®Google Scholar
• Mahler M. E., Benson D. F. Cognitive dysfunction in multiple sclerosis: a subcortical dementia?. Neurobehavioral aspects of multiple sclerosis, S. M. Rao. Oxford University Press, New York 1990; 88–101
   Google Scholar
• Marsh G. G. Disability and intellectual function in multiple sclerosis patients. Journal of Nervous and Mental Disease 1980; 168: 758–762
   PubMed Web of Science ®Google Scholar
• Medaer R., Nelissen E., Appel B. Magnetic resonance imaging and cognitive functioning in multiple sclerosis. Journal of Neurology 1987; 235: 86–89
   PubMed Web of Science ®Google Scholar
• Mendez M. F., Frey W. H. Multiple sclerosis dementia. Neurology 1992; 42: 696
   PubMed Web of Science ®Google Scholar
• Mesulam M. M. Frontal cortex and behavior. Annals of Neurology 1986; 19: 320–325
   PubMed Web of Science ®Google Scholar
• Miledi R. Transmitter release induced by injection of calcium ions into nerve terminals. Proceedings of the Royal Society of Biological Sciences 1973; 183: 421–428
   PubMed Web of Science ®Google Scholar
• Morariu M., Klutzow W. F. Subclinical multiple sclerosis. Journal of Neurology1 1976; 213: 71–76
   PubMed Web of Science ®Google Scholar
• Murray T. J. The treatment of fatigue in MS. Neurology 1984; 34: 139, suppl
   PubMed Web of Science ®Google Scholar
• Murray T. J. Amantadine therapy for fatigue in multiple sclerosis. Canadian Journal of Neurological Sciences 1985; 12: 251–254
   PubMed Web of Science ®Google Scholar
• Pazo J. H. Effects of melatonin on spontaneous and evoked neuronal activity in the mesencephalic reticular formation. Brain Research Bulletin 1979; 4: 725–730
   PubMed Web of Science ®Google Scholar
• Peyser J. M., Rao S. M., LaRocca N. G., Kaplan E. Guidelines for neuropsychological research in multiple sclerosis. Archives of Neurology 1990; 47: 94–97
   PubMed Web of Science ®Google Scholar
• Phadke J. G., Best P. V. Atypical and clinically silent multiple sclerosis: a report of 12 cases discovered unexpectedly at necropsy. Journal of Neurology, Neurosurgery and Psychiatry 1983; 46: 414–420
   PubMed Web of Science ®Google Scholar
• Plaut G. S. Effectiveness of amantadine in reducing relapses in multiple sclerosis. Journal of the Royal Society of Medicine 1987; 80: 91–93
   PubMed Web of Science ®Google Scholar
• Poser C. M. Multiple sclerosis, observations and reflections-a personal memoir. Journal of the Neurological Sciences 1992; 107: 127–140
   PubMed Web of Science ®Google Scholar
• Rao N. A. Chronic experimental allergic optic neuritis. Investigate Ophthalmology and Visual Sciences 1981; 20: 159–172
   PubMed Web of Science ®Google Scholar
• Rao S. M. Neuropsychology of multiple sclerosis: a critical review. Journal of Clinical and Experimental Neuropsychology 1986; 8: 503–542
   PubMed Web of Science ®Google Scholar
• Rao S. M. Neuroimaging correlates of cognitive dysfunction. Neurobehavioral aspects of multiple sclerosis, S. M. Rao. Oxford University Press, New York 1990; 118–135
   Google Scholar
• Rao S. M., Hammeke T. A. Hypothesis testing in patients with chronic progressive multiple sclerosis. Brain and Cognition 1984; 3: 94–104
   PubMed Web of Science ®Google Scholar
• Rao S. M., Hammeke T. A., McQuillen M. P., Khatri B. O., Lloyd D. Memory disturbance in chronic progressive multiple sclerosis. Archives of Neurology 1984; 41: 625–631
   PubMed Web of Science ®Google Scholar
• Rao S. M., Glatt S., Hammeke T. A. Chronic progressive multiple sclerosis: relationship between cerebral ventricular size and neuropsychological impairment. Archives of Neurology 1985; 42: 678–682
   PubMed Web of Science ®Google Scholar
• Rao S. M., Leo G. J., Bemardin L., Ellington L. Impact of cognitive dysfunction on employment and social functioning in MS patients. Neurology 1989; 39(suppl 1)143
   Google Scholar
• Rao S. M., Huber S. J., Bernstein R. A. Emotional changes with multiple sclerosis and Parkinson's disease. Journal of Consulting and Clinical Psychology 1992; 60: 369–378
   PubMed Web of Science ®Google Scholar
• Reiehardt L. F., Kelly R. B. A molecular description of nerve terminal function. Annual Review of Biochemistry 1983; 52: 871–926
   PubMed Web of Science ®Google Scholar
• Reiter R. J. Changes in circadian melatonin synthesis in the pineal gland of animals exposed to extremely low frequency electromagnetic radiation: A summary of observations and speculation on their implications. Electromagnetic fields and circadian rhythmicity, M. C. Moore-Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 13–27
   Google Scholar
• Reznikoff M., Tomblen D. The use of human figure drawings in the diagnosis of organic pathology. Journal of Consulting Psychology 1956; 20: 467–470
   PubMedGoogle Scholar
• Riklan M., Zahn T. P., Diller L. Human figure drawings before and after chemosurgery of the basal ganglia in Parkinsonism. Journal ofNerrous and Mental Disease 1962; 135: 500–506
   PubMed Web of Science ®Google Scholar
• Rosen A. D. Magnetic field influence on acetylcholine release at the neuromuscular junction. American Journal of Physiology 1992; 262: C1418–C1422, cell physiol. 31
   PubMed Web of Science ®Google Scholar
• Rosen A. D., Lubowsky J. Magnetic fields influence on central nervous system function. Experimental Neurology 1987; 95: 679–687
   PubMed Web of Science ®Google Scholar
• Rosenberg G. A., Appenzeller O. Amantadine, fatigue, and multiple sclerosis. Archives of Neurology 1988; 45: 1104–1106
   PubMed Web of Science ®Google Scholar
• Russel D. S. Trauma and multiple sclerosis. Lancet 1964; 1: 978
   Google Scholar
• Sallanon M., Claustrat B., Touret M. Presence of melatonin in various cat brainstem nuclei determined by radioimmunoassay. Acta Endocrinologica 1982; 101: 161–165
   PubMedGoogle Scholar
• Sandman C. A., George J., Walker B. B., Nolan J. D., Kastin A. J. Neuropeptide MSH/ACTH 4–10 enhances attention in the mentally retarded. Pharmacology. Biochemistry and Behavior 1976; 5(suppl 1)23–28
   PubMed Web of Science ®Google Scholar
• Sandyk R. Successful treatment of multiple sclerosis with magnetic fields. International Journal of Neuroscience 1992; 66: 237–250
   PubMed Web of Science ®Google Scholar
• Sandyk R. Demyelination as an epiphenomenon in multiple sclerosis. International Journal of Neuroscience 1993; 72: 141–148
   PubMedGoogle Scholar
• Sandyk R. Rapid normalization of visual evoked potentials by picotesla range magnetic fields in chronic progressive multiple sclerosis. International Journal ofNeuroscience 1994a; 77: 243–259
   PubMed Web of Science ®Google Scholar
• Sandyk R. Further observations on the effects of external picotesla range magnetic fields on visual memory and visuospatial functions in multiple sclerosis. International Journal of Neuroscience 1994b; 77: 203–227
   PubMed Web of Science ®Google Scholar
• Sandyk R. Improvement in word fluency performance in patients with multiple sclerosis by electromagnetic fields. International Journal ofNeuroscience 1994c; 79: 75–90
   PubMed Web of Science ®Google Scholar
• Sandyk R. Reversal of visuospatial hemi-inattention in patients with chronic progressive multiple sclerosis by treatment with weak electromagnetic fields. International Journal of Neuroscience 1994d; 79: 169–184
   PubMedGoogle Scholar
• Sandyk R. Long term beneficial effects of weak electromagnetic fields in multiple sclerosis. International Journal of Neuroscience 1995a; 83: 45–57
   PubMed Web of Science ®Google Scholar
• Sandyk R. Reversal of alexia in multiple sclerosis by weak electromagnetic fields. International Journal ofNeuroscience 1995b; 83: 69–79
   PubMed Web of Science ®Google Scholar
• Sandyk R. Effect of weak electromagnetic fields on body image perception in patients with multiple sclerosis. International Journal ofNeuroscience 1996; 86: 79–85
   PubMed Web of Science ®Google Scholar
• Sandyk R. Progressive cognitive improvement in multiple sclerosis from treatment with electromagnetic fields. International Journal of Neuroscience
   Web of Science ®Google Scholar
• Sandyk R., Derpapas K. Successful treatment of an acute exacerbation of multiple sclerosis by external magnetic fields. International Journal ofNeuroscience 1993a; 70: 97–105
   PubMedGoogle Scholar
• Sandyk R., Derpapas K. The effects of external picotesla range magnetic fields on the EEG in Parkinson's disease. International Journal ofNeuroscience 1993b; 70: 85–96
   PubMedGoogle Scholar
• Sandyk R., Derpapas K. The effects of picotesla range magnetic fields on visuospatial functions in multiple sclerosis. International Journal ofNeuroscience 1994; 78: 103–109
   PubMed Web of Science ®Google Scholar
• Sandyk R., Lacono R. P. Resolution of longstanding symptoms of multiple sclerosis by application of picotesla range magnetic fields. International Journal of Neuroscience 1993; 70: 255–269
   PubMed Web of Science ®Google Scholar
• Sandyk R., Lacono R. P. Improvement by picotesla magnetic fields of perceptual-motor performance in a patient with chronic progressive multiple sclerosis. International Journal of Neuroscience 1994a; 78: 53–66
   PubMed Web of Science ®Google Scholar
• Sandyk R., Lacono R. P. Multiple sclerosis: Improvement of visuoperceptive functions by picotesla range magnetic fields. International Journal ofNeuroscience 1994b; 74: 177–189
   PubMedGoogle Scholar
• Schafer E. W. P., McKean C. M. Evidence that monoamines influence human evoked potentials. Brain Research 1975; 99: 49–58
   PubMed Web of Science ®Google Scholar
• Schapiro R. T. Symptom management in multiple sclerosis. Annals of Neurology 1994; 36: S123–S129
   PubMed Web of Science ®Google Scholar
• Shontz F. C. Body concept disturbances of patients with hemiplegia. Journal of Clinical Psychology 1956; 12: 293–295
   PubMed Web of Science ®Google Scholar
• Sonninen V., Riekkinen P., Rinne U. K. Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology 1973; 23: 760–763
   PubMed Web of Science ®Google Scholar
• Stankov B., Fraschini F., Reiter R. J. Melatonin binding sites in the central nervous system. Brain Research 1991; 16: 245–256
   Web of Science ®Google Scholar
• Staples D., Lincoln N. B. Intellectual impairment in multiple sclerosis. Rheumatology & Rehabilitation 1979; 18: 153–160
   PubMedGoogle Scholar
• Surridge D. An investigation into some psychiatric aspects of multiple sclerosis. British Journal of Psychiatry 1969; 115: 749–764
   PubMed Web of Science ®Google Scholar
• Tabaddor K., Wolfson L. I., Sharpless N. S. Ventricular fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in patients with movement disorders. Neurology 1978; 28: 1249–1253
   PubMed Web of Science ®Google Scholar
• Vost A., Wolochow D. A., Howell D. A. Incidence of infarcts of the brain in hear disease. Journal of Pathology & Bacteriology 1964; 88: 463–170
   PubMedGoogle Scholar
• Vuia O. The benign form of multiple sclerosis: anatomo-clinical aspects. Acta Neurologica Scandinavica 1977; 55: 289–293
   PubMed Web of Science ®Google Scholar
• Weinshenker B. G., Penman M., Bass B., Ebers G. C., Rice G. P. A. A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis. Neurology 1992; 42: 1468–1471
   PubMed Web of Science ®Google Scholar
• Weinstein E. A., Kahn R. L. Denial of illness. Thomas Springfield, Illinois 1955
   Google Scholar
• Welker H. A., Semm P., Willig R. P., Commentz J. C., Wiltschko W., Vollrath L. Effects of an artificial magnetic field on serotonin N-acetyltransferase activity and melatonin content of the rat pineal gland. Experimental Brain Research 1983; 50: 426–432
   PubMed Web of Science ®Google Scholar
• White R. F. Emotional and cognitive correlates of multiple sclerosis. Journal of Neuropsychiatry 1990; 2: 422–128
   PubMedGoogle Scholar
• Whitham R. H. Cognitive and emotional disorders. Multiple sclerosis: current status of research and treatment, Robert M. Herndon, Frederick J. Seil. Demos Publications, New York 1994; 189–209
   Google Scholar
• Wilson B. W., Stevens R. G., Anderson L. E. Neuroendocrine mediated effects of electromagnetic field exposure: possible role of the pineal gland. Life Sciences 1989; 45: 1319–1332
   PubMed Web of Science ®Google Scholar
• Winsiewski H. M. A. B. Chronic relapsing exprimental allergic encephalomyelitis. An experimental model of multiple sclerosis. Annals of Neurologyntern 1977; 1: 144–148
   PubMed Web of Science ®Google Scholar
• Young A. C., Saunders J., Ponsford J. R. Mental change as an early feature of multiple sclerosis. Journal of Neurology Neurosurgery and Psychiatry, 39: 1008–1013
   PubMed Web of Science ®Google Scholar
• Young I. R., Hall A. S., Pallis C. A. Nuclear magnetic resonance imaging of the brain in multiple sclersosis. Lincet 1981; 2: 1063–1066
   PubMed Web of Science ®Google Scholar
• Zeise M. L., Semm P. Melationin lowers excitability of guinea pig hippocampal neurons in vitro. Journal of Comparative Physilogy 1985; 157: 23–29
   Google Scholar